Groups 1–3 received PEG-IFN for 4, 8, and 12 weeks, respectively. Among the 40 patients randomized, SVR24 was achieved by 100% of patients, irrespective of whether they received PEG-IFN or not.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback